We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$356M
AUM Growth
+$21.4M
Cap. Flow
+$13.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
21.9%
Holding
167
New
14
Increased
82
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$6.43M
2
SLB icon
SLB Ltd
SLB
+$3.78M
3
PETM
PETSMART INC
PETM
+$3.64M
4
TSM icon
TSMC
TSM
+$3.11M
5
TM icon
Toyota
TM
+$2.51M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.53M
2
KDP icon
Keurig Dr Pepper
KDP
+$4.88M
3
FFIV icon
F5
FFIV
+$3.47M
4
CA
CA, Inc.
CA
+$2.97M
5
MDT icon
Medtronic
MDT
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 12.43%
3 Industrials 12.11%
4 Energy 9.92%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
76
Philip Morris
PM
$299B
$1M 0.28%
12,280
+1,797
+17% +$145K
DIS icon
77
Walt Disney
DIS
$167B
$999K 0.28%
12,468
-34
-0.3% -$2.63K
BRK.A icon
78
Berkshire Hathaway Class A
BRK.A
$1.1T
$937K 0.26%
5
– –
AXP icon
79
American Express
AXP
$228B
$904K 0.25%
10,045
-300
-3% -$26.8K
CVX icon
80
Chevron
CVX
$383B
$895K 0.25%
7,526
-797
-10% -$92.7K
BAC icon
81
Bank of America
BAC
$433B
$800K 0.22%
46,525
-1,648
-3% -$27.7K
JPM icon
82
JPMorgan Chase
JPM
$933B
$791K 0.22%
13,036
-355
-3% -$20.5K
CL icon
83
Colgate-Palmolive
CL
$73.3B
$780K 0.22%
12,018
+209
+2% +$13.2K
AZN icon
84
AstraZeneca
AZN
$266B
$775K 0.22%
11,939
-101,173
-89% -$6.53M
TER icon
85
Teradyne
TER
$57.2B
$667K 0.19%
33,571
-3,590
-10% -$69.4K
KO icon
86
Coca-Cola
KO
$381B
$650K 0.18%
16,800
+168
+1% +$6.49K
MO icon
87
Altria Group
MO
$113B
$643K 0.18%
17,168
+1,031
+6% +$37.5K
DUK icon
88
Duke Energy
DUK
$98.4B
$642K 0.18%
9,008
+184
+2% +$12.8K
D icon
89
Dominion Energy
D
$61.3B
$640K 0.18%
9,019
– –
KMB icon
90
Kimberly-Clark
KMB
$36.6B
$589K 0.17%
5,575
+220
+4% +$22.8K
MFC icon
91
Manulife Financial
MFC
$74B
$554K 0.16%
28,708
-932
-3% -$17.8K
HVB
92
DELISTED
HUDSON VY HLDG CORP
HVB
$489K 0.14%
25,692
-4,055
-14% -$75.4K
WMT icon
93
Walmart Inc
WMT
$884B
$474K 0.13%
18,603
+516
+3% +$13K
UPS icon
94
United Parcel Service
UPS
$89.5B
$466K 0.13%
4,780
-150
-3% -$14.6K
IDXX icon
95
Idexx Laboratories
IDXX
$44.1B
$461K 0.13%
7,600
– –
FLG
96
Flagstar Bank National Association
FLG
$5.94B
$445K 0.13%
9,223
+10
+0.1% +$486
STJ
97
DELISTED
St Jude Medical
STJ
$420K 0.12%
6,425
-235
-4% -$15.3K
TKR icon
98
Timken Company
TKR
$9.46B
$411K 0.12%
9,779
-6,985
-42% -$287K
SO icon
99
Southern Company
SO
$109B
$406K 0.11%
9,238
+1,606
+21% +$67.3K
GPC icon
100
Genuine Parts
GPC
$17.2B
$404K 0.11%
4,646
-650
-12% -$54.8K
2 3
4
5 6

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Grimes & Company's Q1 2014 Portfolio in Review

As of Q1 2014, Grimes & Company held 167 positions worth $356M, up 6.4% from $335M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Grimes & Company deployed $13.5M of net new capital in Q1 2014, opening 14 new positions and adding to 82 existing holdings. Its largest new stake was Gen Digital: 300,398 shares worth $6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $6.53M trimmed.

  • Grimes & Company's largest Q1 2014 buy was Gen Digital: 300,398 shares worth $6M.
  • Grimes & Company added most to SLB Ltd in Q1 2014, an estimated $3.78M increase.
  • Grimes & Company's biggest Q1 2014 reduction was AstraZeneca, cutting an estimated $6.53M.
  • Grimes & Company fully exited F5 in Q1 2014, selling an estimated $3.47M.
  • Grimes & Company's ten largest holdings make up 22% of its $356M portfolio in Q1 2014.
  • Grimes & Company opened 14 new positions and closed 17 in Q1 2014.
  • Grimes & Company's portfolio value rose 6.4% quarter-over-quarter to $356M.

Based on Grimes & Company's 13F filing for Q1 2014, filed 1 May 2014.